IP Library Granted Patent US 8,465,974
Granted Patent B2
US 8,465,974 · App. 13/243,064 · Granted Jun 18, 2013

Production of human late stage motor neuron progenitor cells

Inventor: Aleksandra J. Poole (San Marcos, CA)
Assignee: California Stem Cell, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,465,974
App. No.
13/243,064
Granted
Jun 18, 2013
Kind
B2
Abstract

Motor neuron progenitor (MNP) cells and populations of MNP cells, are provided, in particular, populations of human late stage MNP cells having a purity of greater than about 65% late stage MNP cells and high-purity populations of MNP cells having greater than 95% viable cells, as well as method of making and using the same, including deriving late stage MNP cells from pluripotent embryonic stem cells, producing high-purity populations of late stage MNP cells, producing populations of viable MNP cells, transporting viable MNP cells, and transplanting MNP cells.

Claims (21)

1. A method of preparing a population of viable human motor neuron progenitor cells comprising:

(a) obtaining population of human late stage motor neuron progenitor cells having a purity of greater than about 65% late stage motor neuron progenitor cells, wherein the population is cultured on an adherent substrate and provides a layer of motor neuron progenitor cells;

(b) dissociating the layer of motor neuron progenitor cells cultured on the adherent substrate to provide a cell suspension;

(c) allowing the cell suspension to rest in a non-adherent environment for a period of time sufficient for floating microspheres comprising viable cells to form;

(c) selecting the floating microspheres comprising viable cells; and

(d) collecting the microspheres to provide a population of viable human motor neuron progenitor cells.

2. The method of claim 1 , comprising enzymatically dissociating the layer of motor neuron progenitor cells.

3. The method of claim 2 , further comprising washing the cell suspension after dissociating.

4. The method of claim 1 , wherein the non-adherent environment is a low-adherent material or a material coated for minimal cell adhesion.

5. The method of claim 1 , wherein the cell suspension is allowed to rest for between at 6 hours and about 20 hours.

6. The method of claim 1 , comprising selecting the floating microspheres comprising viable cells by gravitational sedimentation of the cell suspension comprising floating microspheres, wherein the floating microspheres comprising viable cells remain in the supernatant and the nonviable cells form a pellet.

7. The method of claim 6 , comprising collecting the microspheres to provide a population of viable human motor neuron progenitor cells by collecting the supernatant.

8. The method of claim 6 , comprising a plurality of selecting steps, wherein the first selecting step comprises gravitational sedimentation of the cell suspension followed by collecting the supernatant of the sedimentation is repeated one or multiple times, a second selecting step comprises sedimentation of the supernatant collected from the first sedimentation followed by collecting the supernatant of the second sedimentation, and wherein optional subsequent selecting steps comprise sedimentation of the supernatant collected from the previous selecting step followed by collecting the supernatant.

9. The method of claim 8 , comprising three selecting steps.

10. The method of claim 1 , further comprising determining the number of viable and nonviable cells present per unit volume of solution after at least one step.

11. The method of claim 1 , wherein population of viable human motor neuron progenitor cells comprises greater than 95% viable cells.

12. A method for preparing a population of viable motor neuron progenitor cells prepared according to the method of claim 1 , for transplantation into a subject, comprising,

(a) determining the number of cells to be transplanted;

(b) determining the volume of supernatant needed to supply the number of cells to be transplanted by measuring the number of viable and nonviable cells in a sample of the cell suspension to determine the total number of viable and nonviable cells in the cell suspension; measuring the number of cells in a sample of discarded material after each step, to determine the total number of discarded viable and nonviable cells; and determining the total number of viable cells in the supernatant containing floating microspheres, by subtracting the total number of discarded viable cells from the total number of viable cells in the cell suspension, further comprising determining the number of viable cells per unit volume of the supernatant;

(c) determining the total volume to be transplanted;

(d) mixing the volume of supernatant needed to supply the number of cells to be transplanted with a volume of transplant vehicle needed to achieve the total volume to be transplanted.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Dec 28, 2016
From: CALIFORNIA STEM CELL, INC.; NBS ACQUISITION SUB II, LLC; NEOSTEM ONCOLOGY, LLC
To: NEOSTEM ONCOLOGY, LLC
Reel/Frame 040787/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2013
From: POOLE, ALEKSANDRA J.
To: CALIFORNIA STEM CELL, INC.
Reel/Frame 030504/0536 →
Continuity (3)
Continuation 12054245 · Mar 24, 2008
Provisional Application 60896758 · Mar 23, 2007
Related Publication 20120014931A1 · Jan 19, 2012